| Literature DB >> 15017106 |
Kaei Moriguchi1, Katsuhiko Yoshizawa, Nobuaki Shikata, Takashi Yuri, Hideho Takada, Takahiko Hada, Airo Tsubura.
Abstract
We evaluated the effects of dietary intake of docosahexaenoic acid (DHA) on photoreceptor cell apoptosis caused by N-methyl-N-nitrosourea (MNU). Five-week-old female Sprague-Dawley rats were fed basal diet (AIN-76A) or DHA diet (modified AIN-76A containing 9.5% DHA) for 2 weeks, and then received a single intraperitoneal injection of 60 mg/kg body weight MNU at 50 days of age. Then, rats continued to receive the same diet or were switched to the opposite diet: group 1, basal diet before and after MNU injection; group 2, DHA diet before MNU injection and basal diet after MNU injection; group 3, basal diet before MNU injection and DHA diet after MNU injection; group 4, DHA diet before and after MNU injection (10 rats in each group). Rats were starved for 24 h, then sacrificed 3 or 7 days after MNU. Morphologically, at 3 days after MNU injection, photoreceptor cell apoptosis was advanced in group 1 compared with group 4. At this time point, as evaluated by retinal damage ratio [(length of retina less than 4 photoreceptor cells thick/whole retinal length) x100], retinal damage was highest in group 1 (82.4 +/- 5.1%), followed by group 2 (41.1 +/- 7.3%), group 3 (24.7 +/- 11.5%), and group 4 (6.6 +/- 6.6%); severity tended to be inversely correlated with serum DHA composition. At 7 days after MNU injection, active signs of photoreceptor cell apoptosis ended in all MNU-treated groups, and retinal damage ratio was high in group 1 (88.4 +/- 2.8%), whereas it remained low in groups 2, 3 and 4 (38.4 +/- 15.2, 45.7 +/- 9.8 and 46.9 +/- 11.2%, respectively). High DHA composition during induction/signaling phase and/or effector phase of photoreceptor cell apoptosis can delay the onset of apoptosis and counteract progression of MNU retinotoxicity in rat retina. DHA may play a role in the suppression of MNU-induced photoreceptor cell apoptosis in rat retina. Copyright 2004 S. Karger AG, BaselEntities:
Mesh:
Substances:
Year: 2004 PMID: 15017106 DOI: 10.1159/000076889
Source DB: PubMed Journal: Ophthalmic Res ISSN: 0030-3747 Impact factor: 2.892